TTK Healthcare Limited has informed the Exchange regarding Appointment of as Chairman of the company w.e.f. November 01, 2026.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TTK Healthcare's Board approved audited Q4 and full-year FY2026 results showing revenue from operations of Rs.85,728 lakhs (up 7% YoY) but profit before tax declined 24% to Rs.8,256 lakhs due to exceptional items including Rs.758 lakhs net charge from new labour code provisions. Profit after tax stood at Rs.6,568 lakhs (down 20% from Rs.8,166 lakhs). The Board recommended a dividend of Rs.10 per share (100%) for FY2026, subject to shareholder approval at the July 24 AGM. Mr. T T Raghunathan has been reappointed as Executive Chairman for another 5-year term starting November 1, 2026. M/s Geeyes & Co. was appointed as the Cost Auditor for FY2026-27.
While revenue grew modestly, the significant profit decline may create short-term pressure on the stock. The maintained dividend and leadership continuity provide some support for investor confidence.